Assessing the effectiveness of camrelizumab plus apatinib versus sorafenib for the treatment of primary liver cancer: a single-center retrospective study.

Chen, Dongbo; Wang, Yichun; Chen, Xiangxun; Kang, Mei; Zhu, Liyang

Chen, Dongbo; Wang, Yichun; Chen, Xiangxun; Kang, Mei; Zhu, Liyang.

Afiliação

Chen D; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, No. 120, Wanshui Road, Hefei, 230000, Anhui, People's Republic of China.
Wang Y; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, No. 120, Wanshui Road, Hefei, 230000, Anhui, People's Republic of China.
Chen X; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, No. 120, Wanshui Road, Hefei, 230000, Anhui, People's Republic of China.
Kang M; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, No. 120, Wanshui Road, Hefei, 230000, Anhui, People's Republic of China.
Zhu L; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, No. 120, Wanshui Road, Hefei, 230000, Anhui, People's Republic of China. 773080192@qq.com.

Sci Rep ; 13(1): 13285, 2023 08 16.

Article em En | MEDLINE | ID: mdl-37587189

Assuntos

Neoplasias Hepáticas; Humanos; Estudos Retrospectivos; Sorafenibe/uso terapêutico; Neoplasias Hepáticas/tratamento farmacológico; Peso Corporal

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Neoplasias Hepáticas Tipo de estudo: Observational_studies Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google